CID is 457193
synonyms found at PubChem are:
DACTINOMYCIN, actinomycin D, Actinomycin C1, Cosmegen, Actinomycin IV, 50-76-0, Meractinomycin, ActD, UNII-1CC1JFE158, Dactinomicina, Dactinomycine, Dactinomycinum, Actinomycin 7, GNF-Pf-2290, MLS001424196, 1CC1JFE158, CHEBI:27666, Actactinomycin A IV, Dilactone actinomycindioic D acid, NCGC00161622-02, SMR000469227, DSSTox_CID_31, Cosmegen Lyovac, Lyovac-Cosmegen, DSSTox_RID_75330, DSSTox_GSID_20031, Actinomycin, NCI-C04682, NSC 3053, EINECS 200-063-6, CAS-50-76-0, ACT [antibiotic], 2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide, AI3-26374, NSC3053, Glycopeptide, 4a, 3H-Phenoxazine-1,9-dicarboxamide, 2-amino-N,N'-bis(hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-i)(1,4,7,10,13)oxatetra-azacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-, Specific stereoisomer of N,N'-((2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-diyl)-bis(carbonylimino(2-hydroxypropylidene)carbonyliminoisobutylidenecarbonyl-1,2-pyrrolidinediylcarbonyl(methylimino)methylenecarbonyl))bis(N-methyl-L-valine) dilactone, Stereoisomer of N,N'-((2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-diyl)bis(carbonylimino(2-(1-hydroxyethyl)-1-oxo-2,1-ethanediyl)imino(2-(1-methylethyl)-1-oxo-2,1-ethanediyl)-1,2-pyrrolidinediylcarbonyl(methylimino) (1-oxo-2,1-ethanediyl)))bis(N-methyl-L-valine)di-xi-lactone, Dactinomycin [USAN:USP:INN:BAN], PXZ-THR-DVA-PRO-SAR-MVA-THR-DVA-PRO-SAR-MVA, UPCMLD-DP055, SCHEMBL3844, CHEMBL1554, DVA-DPR-SAR-MVA-(c1)DTH-PXZ-(c11)DTH-DVA-DPR-SAR-MVA, AC1L9W52, cid_457193, CHEMBL3792960, DTXSID9020031, UPCMLD-DP055:001, UPCMLD-DP055:002, BDBM43866, CTK8F7580, MolPort-003-925-177, RJURFGZVJUQBHK-IIXSONLDSA-N, HMS2052O17, 2-amino-4,6-dimethyl-3-oxo-N,N'-bis[(6S,9R,10S,13R,18aS)-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxohexadecahydro-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-10-yl]-3H-phenoxazine-1,9-dicarboxamide, Tox21_111997, Tox21_202482, BDBM50089528, MFCD00005033, AKOS030228553, Tox21_111997_1, CCG-101134, DB00970, NC00384, NCGC00090796-01, NCGC00161622-01, NCGC00260031-01, NCGC00271789-02, CPD000469227, SAM001246846, FT-0080366, 15160-EP2272827A1, 15160-EP2275420A1, 15160-EP2280012A2, 15160-EP2281815A1, 15160-EP2289892A1, 15160-EP2292615A1, 15160-EP2295055A2, 15160-EP2295416A2, 15160-EP2295426A1, 15160-EP2295427A1, 15160-EP2298748A2, 15160-EP2298764A1, 15160-EP2298765A1, 15160-EP2301928A1, 15160-EP2301933A1, 15160-EP2305640A2, 15160-EP2305642A2, 15160-EP2305671A1, 15160-EP2308833A2, 15160-EP2311453A1, 15160-EP2311808A1, 15160-EP2311827A1, 15160-EP2311829A1, 15160-EP2311842A2, 15160-EP2316832A1, 15160-EP2316833A1, AB00514445-05, 050A760, SR-01000763161, SR-01000763161-4, Actinomycin D, from Streptomyces sp., >=95% (HPLC), Actinomycin D, from Streptomyces sp., ~98% (HPLC), BRD-K70578146-001-01-8, BRD-K70578146-001-04-2, UNII-0OCC969V50 component RJURFGZVJUQBHK-IIXSONLDSA-N, Dactinomycin, United States Pharmacopeia (USP) Reference Standard, Actinomycin D, for fluorescence, >=90% (HPLC), from Streptomyces sp., Actinomycin D, from Streptomyces sp., suitable for cell culture, >=95%, 1-N,9-N-bis[(6S,9R,10S,13R,18aS)-2,5,9-trimethyl-1,4,7,11,14-pentaoxo-6,13-bis(propan-2-yl)-hexadecahydro-1H-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl]-2-amino-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide, 2-Amino- 4,6-dimethyl- 3-oxo- 3H-phenoxazine- 1,9-dicarboxylic acid bis- [(5,12-diisopropyl- 9,13,16-trimethyl- 4,7,11,14,17-pentaoxo- hexadecahydro- 10-oxa- 3a,6,13,16-tetraaza- cyclopentacyclohexadecen- 8-yl)- amide], 2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis-[(18aS)-10c,14,17-trimethyl-5,8,12,15,18-pentaoxo-6c,13t-di(propan-2-yl)-18ar-hexadecahydro-1H-pyrrolo[2,1-i][1,4,7,10,13]oxatetraazacyclohexadecin-9c-yl]-3H-phenoxazine-1,9-dicarboxamide, 2-amino-4,6-dimethyl-3-oxo-N1,N9-bis[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide, 2-amino-N,N''''''''-bis[(3R,6S,7R,10S,16S)-3,10-diisopropyl-2,5,9,12,15-pentaketo-7,11,14-trimethyl-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-3-keto-4,6-dimethyl-phenoxazine-1,9-dicarboxamide, 2-amino-N,N''''-bis[(3R,6S,7R,10S,16S)-3,10-diisopropyl-2,5,9,12,15-pentaketo-7,11,14-trimethyl-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-3-keto-4,6-dimethyl-phenoxazine-1,9-dicarboxamide, 2-amino-N,N''-bis[(3R,6S,7R,10S,16S)-3,10-diisopropyl-2,5,9,12,15-pentaketo-7,11,14-trimethyl-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-3-keto-4,6-dimethyl-phenoxazine-1,9-dicarboxamide, 2-amino-N,N'-bis(hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-i)(1,4,7,10,13)oxatetra-azacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide, 2-amino-N1,N9-bis[(3R,6S,7R,10S,16S)-3,10-diisopropyl-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-4,6-dimethyl-3-oxo-phenoxazine-1,9-dicarboxamide, 2-azanyl-4,6-dimethyl-3-oxidanylidene-N1,N9-bis[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentakis(oxidanylidene)-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide